 |
ACADIA Pharmaceuticals
ACAD
|
-21.1 |
$ 22.5 |
1.86 % |
$ 3.73 B |
USA |
 |
MorphoSys AG
MOR
|
-0.591 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Acorda Therapeutics
ACOR
|
0.777 |
- |
-24.86 % |
$ 820 K |
USA |
 |
Adverum Biotechnologies
ADVM
|
-1.32 |
- |
- |
$ 86.2 M |
USA |
 |
AlloVir
ALVR
|
-3.61 |
- |
4.14 % |
$ 49.1 M |
USA |
 |
Alnylam Pharmaceuticals
ALNY
|
-31.5 |
$ 327.16 |
2.39 % |
$ 42.9 B |
USA |
 |
Applied Molecular Transport
AMTI
|
-1.19 |
- |
- |
$ 10.1 M |
USA |
 |
Amgen
AMGN
|
10.7 |
$ 349.22 |
2.71 % |
$ 188 B |
USA |
 |
Amphastar Pharmaceuticals
AMPH
|
17.3 |
$ 20.4 |
-0.87 % |
$ 954 M |
USA |
 |
Applied Therapeutics
APLT
|
-0.476 |
- |
- |
$ 8.42 M |
USA |
 |
I-Mab
IMAB
|
595 |
- |
- |
$ 866 M |
China |
 |
Aquestive Therapeutics
AQST
|
-7.26 |
$ 4.18 |
1.33 % |
$ 447 M |
USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 |
- |
- |
$ 40.3 B |
USA |
 |
Genfit SA
GNFT
|
4.22 K |
- |
2.54 % |
$ 160 B |
France |
 |
Arcutis Biotherapeutics
ARQT
|
-4.86 |
$ 24.57 |
5.59 % |
$ 3.13 B |
USA |
 |
Biophytis SA
BPTS
|
-17.6 |
- |
-13.47 % |
$ 169 M |
France |
 |
AVROBIO
AVRO
|
0.957 |
- |
1083.1 % |
$ 745 M |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.785 |
- |
- |
$ 7.46 M |
Israel |
 |
AstraZeneca PLC
AZN
|
76.5 |
- |
- |
$ 96.9 B |
Britain |
 |
Midatech Pharma plc
MTP
|
0.796 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Autolus Therapeutics plc
AUTL
|
-1.38 |
$ 1.48 |
8.46 % |
$ 394 M |
Britain |
 |
BeiGene, Ltd.
BGNE
|
-208 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Alterity Therapeutics Limited
ATHE
|
-0.994 |
$ 3.85 |
2.41 % |
$ 9.26 B |
Australia |
 |
BioNTech SE
BNTX
|
4.1 |
$ 91.76 |
2.39 % |
$ 27.2 B |
Germany |
 |
CymaBay Therapeutics
CBAY
|
-1.63 K |
- |
- |
$ 3.45 B |
USA |
 |
Advaxis
ADXS
|
-82.4 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Aytu BioScience
AYTU
|
-1.92 |
$ 2.71 |
5.51 % |
$ 17 M |
USA |
 |
Avid Bioservices
CDMO
|
109 |
- |
- |
$ 789 M |
USA |
 |
Cidara Therapeutics
CDTX
|
-1.47 |
- |
- |
$ 1.41 B |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-43.1 |
$ 3.06 |
0.99 % |
$ 6.66 B |
Israel |
 |
Институт стволовых клеток человека
ISKJ
|
14 |
- |
- |
- |
Russia |
 |
Cabaletta Bio
CABA
|
0.778 |
$ 3.06 |
-0.33 % |
$ 307 M |
USA |
 |
Checkpoint Therapeutics
CKPT
|
-0.833 |
- |
- |
$ 169 M |
USA |
 |
Cerus Corporation
CERS
|
-24.7 |
$ 1.9 |
2.99 % |
$ 362 M |
USA |
 |
Coherus BioSciences
CHRS
|
-4.11 |
$ 1.7 |
1.8 % |
$ 199 M |
USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
190 |
$ 0.36 |
0.28 % |
$ 4.12 M |
Israel |
 |
Aeterna Zentaris
AEZS
|
4.4 |
- |
5.93 % |
$ 314 M |
Canada |
 |
Checkmate Pharmaceuticals
CMPI
|
-0.0315 |
- |
- |
$ 231 M |
USA |
 |
AgeX Therapeutics
AGE
|
-1.85 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Concert Pharmaceuticals
CNCE
|
-0.193 |
- |
- |
$ 401 M |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
-4.27 |
- |
- |
$ 1.01 B |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.546 |
- |
- |
$ 26.5 M |
USA |
 |
Catalyst Pharmaceuticals
CPRX
|
7.16 |
$ 25.57 |
2.3 % |
$ 3.13 B |
USA |
 |
CTI BioPharma Corp.
CTIC
|
-0.985 |
- |
- |
$ 1.2 B |
USA |
 |
AIkido Pharma
AIKI
|
-45.5 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Aptose Biosciences
APTO
|
388 |
- |
-45.71 % |
$ 1.2 M |
Canada |
 |
Cyclacel Pharmaceuticals
CYCCP
|
-0.975 |
- |
-4.36 % |
$ 27 M |
USA |
 |
Cellectar Biosciences
CLRB
|
1.31 |
$ 2.81 |
2.18 % |
$ 7.33 M |
USA |
 |
Deciphera Pharmaceuticals
DCPH
|
-1.5 |
- |
- |
$ 2.18 B |
USA |